Citations

Mayo Clinic

Clear

835 citation(s) found for "Sáez, Elena".

Exome analysis identifies Brody myopathy in a family diagnosed with malignant hyperthermia susceptibility
Sambuughin, Nyamkhishig , Zvaritch, Elena, Kraeva, Natasha , Sizova, Olga , Sivak, Erica L. , Dickson, Kelley M, Weglinski, Margaret R., Capacchione, John F., Muldoon, Sheila M., Brandom, Barbara W., MacLennan, David H. , Weglinski, Margaret, Riazi, Sheila , Hamilton, Susan L.

Molecular Genetics & Genomic Medicine | June 6, 2014 | Volume: 2 | Issue: 6 | Pages: 472-483

10.1002/mgg3.91 | PMID 25614869 Get It

AbstractWhole exome sequencing (WES) was used to determine the primary cause of muscle disorder in a family diagnosed with a mild, undetermined myopathy and malignant hyperthermia (MH) susceptibility (MHS). WES revealed the compound heterozygous mutations, p.Ile235Asn and p.Glu982Lys, in ATP2A1, encoding the sarco(endo)plasmic reticulum Ca2+ ATPase type 1 (SERCA1), a calcium pump, expressed in fast‐twitch muscles. Recessive mutations in ATP2A1 are known to cause Brody myopathy, a rare muscle disorder characterized by exercise‐induced impairment of muscle relaxation and stiffness. Analyses of affected muscles showed the absence of SERCA1, but SERCA2 upregulation in slow and fast myofibers, suggesting a compensatory mechanism that partially restores the diminished Ca2+ transport in Brody myopathy. This compensatory adaptation to the lack of SERCA1 Ca2+ pumping activity within the muscle explains, in part, the mild course of disease in our patient. Diagnosis of MHS in this family was secondary to a loss of SERCA1 due to disease‐associated mutations. Although there are obvious differences in clinical expression and molecular mechanisms between MH and Brody myopathy, a feature common to both conditions is elevated myoplasmic Ca2+ content. Prolonged intracellular Ca2+ elevation is likely to have led to MHS diagnosis in vitro and postoperative MH‐like symptoms in Brody patient.
Pooling Prospective Studies to Investigate the Etiology of Second Cancers
Black, Amanda , Gibson, Todd M. , Park, Yikyung , Weinstein, Stephanie J. , Andreotti, Gabriella , Purdue, Mark P. , Fraumeni, Joseph F., Hartge, Patricia, Tucker, Margaret A. , Hoover, Robert N. , Cerhan, James R. , Zeleniuch‐Jacquotte, Anne , Curtis, Rochelle E. , Elena, Joanne W. , González, Amy Berrington de , Morton, Lindsay M. , Shiels, Meredith S. , Robien, Kim , Albanes, Demetrius , Freeman, Laura E. Beane , Sampson, Joshua N. , Cerhan, James R , Morton, Lindsay M , Berrington de Gonzalez, Amy , Gibson, Todd , Zeleniuch-Jacquotte, Anne

Cancer Epidemiology, Biomarkers & Prevention | May 15, 2014 | Volume: 23 | Issue: 8 | Pages: 1598-1608

10.1158/1055-9965.epi-14-0191 | PMID 24832874 Get It

Abstract Background: With over 13 million cancer survivors in the United States today, second cancers are of rapidly growing importance. However, data on nontreatment risk factors for second cancers are sparse. We explored the feasibility of pooling data from cohort studies of cancer incidence to investigate second cancer etiology. Methods: We combined data from five prospective studies including more than 800,000 individuals. We compared study designs and populations; evaluated availability of and ability to harmonize risk factor data; compared incidence and survival for common first primary malignancies and incidence of second primary malignancies; and estimated sample size requirements. Results: Overall, 96,513 incident, first primary malignancies were diagnosed during 1985 to 2009. Incidence rates and survival following the first primary varied among the cohorts, but most of the heterogeneity could be explained by characteristics of the study populations (age, sex, smoking, and screening rates). A total of 7,890 second primary cancers (excluding original primary site) were identified, yielding sufficient statistical power (≥80%) for detecting modest associations with risk of all second cancers among survivors of common first primary malignancies (e.g., colorectal cancer); however, there were insufficient events for studying survivors of rarer cancers or identifying risk factors for specific second cancers. Conclusions: Pooling data from cohort studies to investigate nontreatment risk factors for second primary cancers seems feasible but there are important methodologic issues—some of which are barriers to specific research questions—that require special attention. Impact: Increased understanding of nontreatment risk factors for second cancers will provide valuable prevention and surveillance information. Cancer Epidemiol Biomarkers Prev; 23(8); 1598–608. ©2014 AACR.
Galectin-1 Drives Pancreatic Carcinogenesis through Stroma Remodeling and Hedgehog Signaling Activation
Martínez‐Bosch, Neus , Fernández‐Barrena, Maite G. , Moreno, Mireia , Ortíz-Zapater, Elena , Munné‐Collado, Jessica, Iglesias, Mar , André, Sabine , Gabius, Hans‐Joachim , Hwang, Rosa F. , Poirier, Françoise, Navas, Carolina, Guerra, Carmen , Fernández-Zapico, Martín E. , Navarro, Pilar , Navarro, Pilar

Cancer Research | May 9, 2014 | Volume: 74 | Issue: 13 | Pages: 3512-3524

10.1158/0008-5472.can-13-3013 | PMID 24812270 Get It

Abstract Despite some advances, pancreatic ductal adenocarcinoma (PDAC) remains generally refractory to current treatments. Desmoplastic stroma, a consistent hallmark of PDAC, has emerged as a major source of therapeutic resistance and thus potentially promising targets for improved treatment. The glycan-binding protein galectin-1 (Gal1) is highly expressed in PDAC stroma, but its roles there have not been studied. Here we report functions and molecular pathways of Gal1 that mediate its oncogenic properties in this setting. Genetic ablation of Gal1 in a mouse model of PDAC (EIa-myc mice) dampened tumor progression by inhibiting proliferation, angiogenesis, desmoplasic reaction and by stimulating a tumor-associated immune response, yielding a 20% increase in relative lifesplan. Cellular analyses in vitro and in vivo suggested these effects were mediated through the tumor microenvironment. Importantly, acinar-to-ductal metaplasia, a crucial step for initiation of PDAC, was found to be regulated by Gal1. Mechanistic investigations revealed that Gal1 promoted Hedgehog pathway signaling in PDAC cells and stromal fibroblasts as well as in Ela-myc tumors. Taken together, our findings establish a function for Gal1 in tumor-stroma crosstalk in PDAC and provide a preclinical rationale for Gal1 targeting as a microenvironment-based therapeutic strategy. Cancer Res; 74(13); 3512–24. ©2014 AACR.
The effect of magnification on sonographically measured nerve cross‐sectional area
Jelsing, Elena J., Presley, James C., Maida, Eugene , Hangiandreou, Nicholas J., Smith, Jay

Muscle & Nerve | May 3, 2014 | Volume: 51 | Issue: 1 | Pages: 30-34

10.1002/mus.24274 | PMID 24796756 Get It

ABSTRACTIntroduction: The primary aim of this investigation was to determine whether use of write‐zoom magnification affects sonographically determined cross‐sectional area (CSA) of peripheral nerves. Methods: CSAs of the median (MN) and posterior interosseous (PIN) nerves were measured in 22 limbs from 11 asymptomatic volunteers using both standard imaging and write‐zoom magnification. CSA measurements were repeated on the same images 1 week later. Results: The average CSA of write‐zoomed images for the MN was significantly larger at both measurement sessions (week 1: 11.1 mm2 write‐zoom vs. 10.0 mm2 standard, P = 0.019; week 2: 11.8 mm2 vs. 10.4 mm2, P = 0.023). Similar differences were noted for the PIN (week 1: 2.3 mm2 vs. 1.9 mm2, P = 0.002; week 2: 2.5 mm2 vs. 1.9 mm2, P = 0.001). Conclusions: Write‐zoom magnification may significantly increase the measured CSA of peripheral nerves. These changes appear to be more substantial when smaller nerves are measured. Muscle Nerve 51: 30–34, 2015
Mycobacterium arupense Flexor Tenosynovitis: Case Report and Review of Antimicrobial Susceptibility Profiles for 40 Clinical Isolates
Beam, Elena , Vasoo, Shawn , Simner, Patricia J. , Rizzo, Marco , Mason, Erin L., Walker, Randall C., Deml, Sharon M., Brown‐Elliott, Barbara A. , Wallace, Richard J. , Wengenack, Nancy L. , Sia, Irene G. , Beam, Elena , Sia, Irene G

Journal of Clinical Microbiology | May 1, 2014 | Volume: 52 | Issue: 7 | Pages: 2706-2708

10.1128/jcm.00277-14 | PMID 24789193 Get It

ABSTRACT We describe a case of chronic tenosynovitis in the hand of a 58-year-old cattle farmer. Surgical biopsy specimens grew Mycobacterium arupense . The patient responded to surgery and antimicrobial therapy based on in vitro susceptibility testing. The antimicrobial susceptibility profiles of the isolate from this patient and 39 additional clinical isolates are presented.
Impact of urinary tract infection on allograft function after kidney transplantation
Ariza‐Heredia, Ella , Beam, Elena , Lesnick, Timothy G. , Cosio, Fernando G., Kremers, Walter K. , Ariza-Heredia, Ella J, Razonable, Raymund R. , Beam, Elena , Kremers, Walter K

Clinical Transplantation | March 22, 2014 | Volume: 28 | Issue: 6 | Pages: 683-690

10.1111/ctr.12366 | PMID 24654771 Get It

AbstractObjectivesUrinary tract infection (UTI) is the most common infectious complication after kidney transplantation. We aim to determine its impact on allograft function as indicated by several measures such as iothalamate glomerular filtration rate (iGFR), estimated glomerular filtration rate (eGFR), and creatinine value.MethodsWe performed a single‐center retrospective cohort study to determine the impact ofUTIon kidney allograft outcome.ResultsThe study population consisted of 301 kidney transplant recipients; 84% were living donor transplants. One hundred and one patients (34%) developed at least one episode ofUTIand the incidence ofUTIduring the first year after transplantation was 25%. At the end of the follow‐up, theiGFRwas lower among patients who had developed at least oneUTI(p = 0.044). However,eGFRand creatinine values were not significantly different betweenUTIand non‐UTIgroups.ConclusionWhen kidney function was measured byeGFRand creatinine, there was no significant difference in allograft function between kidney recipients with or withoutUTI. However, when kidney function was measured by nuclear studies, there was a tendency toward impairment in allograft function among patients who developed atleast oneUTIafter transplantation.
Anion exchanger 2 is critical for CD8+ T cells to maintain pHi homeostasis and modulate immune responses
Concepcion, Axel R. , Salas, January T., Sarvide, Sarai , Sáez, Elena , Ferrer, Alex, López, María , Portu, Ainhoa, Bañales, Jesús M. , Hervás‐Stubbs, Sandra , Prìeto, Jesús , Medina, Juan F., Ferrer, Alejandro , Ferrer, Alex, Elferink, Ronald P.J. Oude , Banales, Jesus M , Ferrer, Alejandro , Hervás-Stubbs, Sandra

European Journal of Immunology | February 11, 2014 | Volume: 44 | Issue: 5 | Pages: 1341-1351

10.1002/eji.201344218 | PMID 24515893 Get It

Mitogenic stimulation of lymphocytes involves alkalinization of intracellular pH (pHi). Subsequent pHi regulation may involve HCO3− extrusion through Cl−/HCO3− exchangers and/or Na+‐HCO3− co‐transporters with acid‐loading capability. Abnormalities in these mechanisms could result in immune dysfunctions, as suggested by the CD8+ T‐cell expansion encountered in mice lacking Ae2 (a widely expressed acid loader with electroneutral and Na+‐independent Cl−/HCO3− anion‐exchange activity). Here we report that CD8+ T cells but not CD4+ T cells or other lymphocyte populations, are crucially dependent on Ae2 for pHi regulation. While total lymphocytes (including isolated CD4+ T cells) exhibit Ae1 expression and Na+‐HCO3− co‐transport with acidifying potential, CD8+ T cells lack these acid‐loading mechanisms. In Ae2‐KO mice, CD4+ but not CD8+ T cells upregulate these potential Ae2 surrogates. As a consequence, Ae2‐KO CD8+ T cells exhibit alkalinized pHi, and dramatically increase their pHi upon CD3 stimulation. Moreover, stimulated Ae2‐deficient CD8+ T cells show enhanced intracellular production of IL‐2 and membrane expression of its receptor IL‐2Rα, together with increased cell proliferation and activation. These findings demonstrate that CD8+ T cells are critically dependent on Ae2 for pHi homeostasis and tuning of cell proliferation and activation. Ae2 thus constitutes a novel target to modulate CD8+ T‐cell responses.
American Society of Clinical Oncology Expert Statement: Collection and Use of a Cancer Family History for Oncology Providers
Lu, Karen H. , Wood, Marie , Daniels, Molly S. , Burke, Cathy, Ford, James M. , Kauff, Noah D. , Kohlmann, Wendy , Lindor, Noralane M. , Mulvey, Therese M. , Robinson, Linda, Rubinstein, Wendy S. , Snyder, Carrie, Merrill, Janette K. , Wollins, Dana S., Hughes, Kevin S. , Stoffel, Elena M. , Syngal, Sapna , Hughes, Kevin

Journal of Clinical Oncology | February 4, 2014 | Volume: 32 | Issue: 8 | Pages: 833-840

10.1200/jco.2013.50.9257 | PMID 24493721 Get It

Morbillivirus Control of the Interferon Response: Relevance of STAT2 and mda5 but Not STAT1 for Canine Distemper Virus Virulence in Ferrets
Svitek, Nicholas , Gerhauser, Ingo , Gonçalves, Christophe , Grabski, Elena, Döring, Marius , Kalinke, Ulrich , Anderson, Danielle E. , Cattaneo, Roberto , Messling, Veronika von

Journal of Virology | December 27, 2013 | Volume: 88 | Issue: 5 | Pages: 2941-2950

10.1128/jvi.03076-13 | PMID 24371065 Get It

ABSTRACT The V proteins of paramyxoviruses control the innate immune response. In particular, the V protein of the genus Morbillivirus interferes with the signal transducer and activator of transcription 1 (STAT1), STAT2, and melanoma differentiation-associated protein 5 (mda5) signaling pathways. To characterize the contributions of these pathways to canine distemper virus (CDV) pathogenesis, we took advantage of the knowledge about the mechanisms of interaction between the measles virus V protein with these key regulators of innate immunity. We generated recombinant CDVs with V proteins unable to properly interact with STAT1, STAT2, or mda5. A virus with combined STAT2 and mda5 deficiencies was also generated, and available wild-type and V-protein-knockout viruses were used as controls. Ferrets infected with wild-type and STAT1-blind viruses developed severe leukopenia and loss of lymphocyte proliferation activity and succumbed to the disease within 14 days. In contrast, animals infected with viruses with STAT2 or mda5 defect or both STAT2 and mda5 defects developed a mild self-limiting disease similar to that associated with the V-knockout virus. This study demonstrates the importance of interference with STAT2 and mda5 signaling for CDV immune evasion and provides a starting point for the development of morbillivirus vectors with reduced immunosuppressive properties. IMPORTANCE The V proteins of paramyxoviruses interfere with the recognition of the virus by the immune system of the host. For morbilliviruses, the V protein is known to interact with the signal transducer and activator of transcription 1 (STAT1) and STAT2 and the melanoma differentiation-associated protein 5 (mda5), which are involved in interferon signaling. Here, we examined the contribution of each of these signaling pathways to the pathogenesis of the carnivore morbillivirus canine distemper virus. Using viruses selectively unable to interfere with the respective signaling pathway to infect ferrets, we found that inhibition of STAT2 and mda5 signaling was critical for lethal disease. Our findings provide new insights in the mechanisms of morbillivirus immune evasion and may lead to the development of new vaccines and oncolytic vectors.